{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T11:20:41Z","timestamp":1774696841222,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T00:00:00Z","timestamp":1708560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005155","name":"Azrieli Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016608","name":"Rainwater Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.nucmedbio.2024.108891","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T07:23:08Z","timestamp":1708327388000},"page":"108891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies"],"prefix":"10.1016","volume":"130-131","author":[{"given":"Cassis","family":"Varlow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chester A.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108891_bb0005","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.nucmedbio.2024.108891_bb0010","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1021\/acschemneuro.0c00801","article-title":"Radiosynthesis, in vitro and in vivo evaluation of [18F]CBD-2115 as a first-in-class radiotracer for imaging 4R-tauopathies","volume":"12","author":"Lindberg","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"15","key":"10.1016\/j.nucmedbio.2024.108891_bb0015","doi-asserted-by":"crossref","first-page":"10628","DOI":"10.1021\/acs.jmedchem.3c00775","article-title":"In silico discovery and subsequent characterization of potent 4R-Tauopathy positron emission tomography radiotracers","volume":"66","author":"Graham","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2024.108891_bb0020","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.nucmedbio.2024.108891_bb0025","first-page":"1754","article-title":"18F-PI-2620 tau PET improves the imaging diagnosis of progressive supranuclear palsy","volume":"63","author":"Messerschmidt","year":"2022","journal-title":"J Nucl Med"},{"issue":"9","key":"10.1016\/j.nucmedbio.2024.108891_bb0030","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/mds.28624","article-title":"Cortical [18F]PI-2620 binding differentiates corticobasal syndrome subtypes","volume":"36","author":"Palleis","year":"2021","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.nucmedbio.2024.108891_bb0035","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer\u2019s disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"10.1016\/j.nucmedbio.2024.108891_bb0040","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/brain\/awab120","article-title":"Discriminatory ability of next-generation tau PET tracers for Alzheimer\u2019s disease","volume":"144","author":"Yap","year":"2021","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nucmedbio.2024.108891_bb0045","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41380-022-01875-2","article-title":"Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer\u2019s disease, corticobasal degeneration and progressive supranuclear palsy brains","volume":"28","author":"Malarte","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.nucmedbio.2024.108891_bb0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2967\/jnumed.122.264404","article-title":"Evaluation of tau radiotracers in chronic traumatic encephalopathy","volume":"64","author":"Varlow","year":"2023","journal-title":"J Nucl Med"},{"issue":"3","key":"10.1016\/j.nucmedbio.2024.108891_bb0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11307-022-01779-1","article-title":"Head-to-head comparison of tau-PET radioligands for imaging TDP-43 in post-mortem ALS brain","volume":"25","author":"Knight","year":"2023","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2024.108891_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112615","volume":"204","author":"Gabellieri","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.nucmedbio.2024.108891_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116528","article-title":"Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core","volume":"52","author":"Kroth","year":"2021","journal-title":"Bioorg Med Chem"},{"issue":"13","key":"10.1016\/j.nucmedbio.2024.108891_bb0060","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","article-title":"Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain","volume":"69","author":"Klunk","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.nucmedbio.2024.108891_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.sbi.2020.05.011","article-title":"Cryo-EM structures of tau filaments","volume":"64","author":"Scheres","year":"2020","journal-title":"Curr Opin Struct Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T04:47:41Z","timestamp":1737002861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":15,"alternative-id":["S0969805124000179"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108891","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro evaluation of [3H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108891","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108891"}}